You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Novel Coronavirus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel

Not yet recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • (no location specified)
Sep 5, 2023

COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus vaccine (CHO Cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 6, 2023

Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

Active, not recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
May 6, 2023

COVID-19 Trial in Beijing (SA55 nasal spray)

Recruiting
  • COVID-19
  • SA55 nasal spray
  • Beijing, Chaoyang, China
    Beijing Ditan Hospital Capital Medical University
Sep 15, 2023

COVID-19 Trial (Ursodeoxycholic acid)

Not yet recruiting
  • COVID-19
  • Ursodeoxycholic acid
  • (no location specified)
Dec 20, 2022

Novel COVID-19-Infected Pneumonia Trial in Changsha (Jaktinib HCl tablets)

Not yet recruiting
  • Novel COVID-19-Infected Pneumonia
  • Jaktinib hydrochloride tablets
  • Changsha, Hunan, China
    Changsha Taihe Hospital
Jan 9, 2023

Novel COVID-19-Infected Pneumonia Trial in Chengdu (Jaktinib HCl tablets)

Not yet recruiting
  • Novel COVID-19-Infected Pneumonia
  • Jaktinib hydrochloride tablets
  • Chengdu, Sichuan, China
    West China Hospital Sichuan University
Jan 9, 2023

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

Vaccination Refusal, COVID-19 Trial in Baltimore (Factual messages, Narrative message, Mixed message)

Completed
  • Vaccination Refusal
  • COVID-19
  • Factual messages
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Mar 1, 2023

COVID-19 Trial in Chengdu (VV116+SOC, SOC)

Recruiting
  • COVID-19
  • Chengdu, Sichuan, China
    Chengdu Zenitar Biomedical Technology Co., Ltd
Feb 3, 2023

Exclusive Breastfeeding in Infants of Mothers Infected With

Completed
  • Covid19
  • +2 more
  • RT-PCR for SARS-Cov-2
  • Istanbul, Kucukcekmece, Turkey
    Kanuni Sultan Suleyman Training and Research Hospital
Nov 18, 2022

COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
  • Taizhou, Jiangsu, China
    Taixing City center for Disease Control and Prevention
Oct 28, 2022

COVID-19 Infection Trial in Nanjing, Nantong, Xuzhou (no intervention)

Recruiting
  • COVID-19 Infection
  • no intervention
  • Nanjing, Jiangsu, China
  • +2 more
Jan 28, 2023

Novel Coronavirus Pneumonia Trial in Xinxiang (NK Cells)

Recruiting
  • Novel Coronavirus Pneumonia
  • NK Cells
  • Xinxiang, Henan, China
    The First Affiliated Hospital of Xinxiang Medical University
Aug 31, 2022

COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

Active, not recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
  • Yancheng, Jiangsu, China
    Funing Center for Disease Control and Prevention
Oct 28, 2022

Corona Virus Disease 2019(COVID-19) Trial in Chengdu (0.3ml of mRNA vaccine)

Enrolling by invitation
  • Corona Virus Disease 2019(COVID-19)
  • 0.3ml of mRNA vaccine
  • Chengdu, China
    West China Second University Hospital
Oct 3, 2022

COVID-19 Trial in Tashkent (Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells), Recombinant Novel

Recruiting
  • COVID-19
  • Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
  • Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
  • Tashkent, Uzbekistan
    Uzbekistan, Tashkent city, Said baraka street 10
Nov 11, 2022

Covid19, Hydrogen-oxygen Gas, AMS-H-03 Trial in Guangzhou (Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03, OLO-1 Medical

Not yet recruiting
  • Covid19
  • +2 more
  • Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03
  • OLO-1 Medical Molecular Sieve Oxygen Generator
  • Guangzhou, Guangdong, China
    First Affiliated Hospital of Guangzhou Medical University
Mar 12, 2023

Oncology Patients to Novel Coronavirus Vaccines (IROC)

Recruiting
  • Cancer
  • COVID-19 Vaccination
  • Carmel, Indiana
  • +1 more
Aug 2, 2022

COVID-19 Trial in Atlanta (Duvelisib, Placebo)

Completed
  • COVID-19
  • Atlanta, Georgia
  • +2 more
Jun 10, 2022

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

Recruiting
  • COVID
    • San Francisco, California
      Zuckerberg San Francisco General Hospital (ZSFG)
    Mar 22, 2022

    COVID-19 Vaccine Trial in Ciudad autónoma de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aires

    Active, not recruiting
    • COVID-19 Vaccine
    • Ad5-nCov
    • Ciudad autónoma de Buenos Aires, Buenos Aires, Argentina
    • +2 more
    Sep 28, 2022

    COVID-19 Pneumonia, Pneumonia Trial in Shenzhen (Jaktinib HCl tablets, Placebo)

    Not yet recruiting
    • COVID-19 Pneumonia
    • Pneumonia
    • Jaktinib hydrochloride tablets
    • Placebo
    • Shenzhen, Guangdong, China
      The Third People Hospital of Shenzhen
    Jan 26, 2023

    Acute Pancreatitis Complicated With COVID-19

    Not yet recruiting
    • Acute Pancreatitis
    • 2019 Novel Coronavirus Infection
      • (no location specified)
      Feb 13, 2023

      Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases

      Active, not recruiting
      • Covid19
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 15, 2022